Publikationen von Yvonne Genzel
Alle Typen
Zeitschriftenartikel (102)
2024
Zeitschriftenartikel
108 (1), 240 (2024)
Production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration. Applied Microbiology and Biotechnology
Zeitschriftenartikel
108, 97 (2024)
Production of antiviral “OP7 chimera” defective interfering particles free of infectious virus. Applied Microbiology and Biotechnology
Zeitschriftenartikel
24 (4), 2300245 (2024)
From single‐cell cloning to high‐yield influenza virus production – implementing advanced technologies in vaccine process development. Engineering in Life Sciences 2023
Zeitschriftenartikel
13, 20936 (2023)
Generation of “OP7 chimera” defective interfering influenza A particle preparations free of infectious virus that show antiviral efficacy in mice. Scientific Reports
Zeitschriftenartikel
120 (9), S. 2639 - 2657 (2023)
Process intensification strategies toward cell culture‐based high‐yield production of a fusogenic oncolytic virus. Biotechnology and Bioengineering
Zeitschriftenartikel
120, S. 3335 - 3346 (2023)
Characterization of a quail suspension cell line for production of a fusogenic oncolytic virus. Biotechnology and Bioengineering
Zeitschriftenartikel
107, S. 5947 - 5961 (2023)
Production of retroviral vectors in continuous high cell density culture. Applied Microbiology and Biotechnology
Zeitschriftenartikel
11, 1076524 (2023)
Novel suspension retroviral packaging cells generated by transposition using transposase encoding mRNA advance vector yields and enable production in bioreactors. Frontiers in Bioengineering and Biotechnology 2022
Zeitschriftenartikel
106, S. 4945 - 4961 (2022)
Cell-line screening and process development for a fusogenic oncolytic virus in small-scale suspension cultures. Applied Microbiology and Biotechnology
Zeitschriftenartikel
259, 104544 (2022)
Absolute quantification of viral proteins during single-round replication of MDCK suspension cells. Journal of Proteomics
Zeitschriftenartikel
11 (22), 3634 (2022)
Human 3D Airway Tissue Models for Real-Time Microscopy: Visualizing Respiratory Virus Spreading. Cells
Zeitschriftenartikel
10 (2), 249 (2022)
High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor. Vaccines
Zeitschriftenartikel
12 (3), 239 (2022)
Impact of Influenza A Virus Infection on Growth and Metabolism of Suspension MDCK Cells Using a Dynamic Model. Metabolites 2021
Zeitschriftenartikel
118 (10), S. 3996 - 4013 (2021)
Towards integrated production of an influenza A vaccine candidate with MDCK suspension cells. Biotechnology and Bioengineering
Zeitschriftenartikel
118 (12), S. 4720 - 4734 (2021)
A high cell density perfusion process for Modified Vaccinia virus Ankara production: process integration with inline DNA digestion and cost analysis. Biotechnology and Bioengineering
Zeitschriftenartikel
16 (1), e2000024 (2021)
Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production. Biotechnology Journal
Zeitschriftenartikel
19 (1), 91 (2021)
Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles. BMC Biology
Zeitschriftenartikel
105, S. 7251 - 7264 (2021)
Cell culture–based production of defective interfering influenza A virus particles in perfusion mode using an alternating tangential flow filtration system. Applied Microbiology and Biotechnology
Zeitschriftenartikel
105 (1), S. 129 - 146 (2021)
OP7, a novel influenza A virus defective interfering particle: production, purification, and animal experiments demonstrating antiviral potential. Applied Microbiology and Biotechnology
Zeitschriftenartikel
9 (7), 706 (2021)
SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor. Vaccines